DE69507697D1 - Verfahren zur herstellung von nalbuphin das wenig des 6-beta-epimers enthält - Google Patents

Verfahren zur herstellung von nalbuphin das wenig des 6-beta-epimers enthält

Info

Publication number
DE69507697D1
DE69507697D1 DE69507697T DE69507697T DE69507697D1 DE 69507697 D1 DE69507697 D1 DE 69507697D1 DE 69507697 T DE69507697 T DE 69507697T DE 69507697 T DE69507697 T DE 69507697T DE 69507697 D1 DE69507697 D1 DE 69507697D1
Authority
DE
Germany
Prior art keywords
pct
nalbuphin
producing
contains little
epimer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69507697T
Other languages
English (en)
Other versions
DE69507697T2 (de
Inventor
Frank Kavka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Chemical Inc
Original Assignee
Mallinckrodt Chemical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Chemical Inc filed Critical Mallinckrodt Chemical Inc
Publication of DE69507697D1 publication Critical patent/DE69507697D1/de
Application granted granted Critical
Publication of DE69507697T2 publication Critical patent/DE69507697T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
DE69507697T 1994-05-31 1995-05-16 Verfahren zur herstellung von nalbuphin das wenig des 6-beta-epimers enthält Expired - Lifetime DE69507697T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25146094A 1994-05-31 1994-05-31
PCT/US1995/006097 WO1995032973A1 (en) 1994-05-31 1995-05-16 The preparation of nalbuphine having low levels of beta-epimer

Publications (2)

Publication Number Publication Date
DE69507697D1 true DE69507697D1 (de) 1999-03-18
DE69507697T2 DE69507697T2 (de) 1999-06-10

Family

ID=22952064

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69507697T Expired - Lifetime DE69507697T2 (de) 1994-05-31 1995-05-16 Verfahren zur herstellung von nalbuphin das wenig des 6-beta-epimers enthält

Country Status (11)

Country Link
US (1) US5756745A (de)
EP (1) EP0763038B1 (de)
JP (1) JP4040673B2 (de)
AT (1) ATE176472T1 (de)
AU (1) AU699114B2 (de)
CA (1) CA2191843C (de)
DE (1) DE69507697T2 (de)
ES (1) ES2127532T3 (de)
HU (1) HU224914B1 (de)
NZ (1) NZ287243A (de)
WO (1) WO1995032973A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19622866C2 (de) * 1996-06-07 1998-12-24 Viva Diagnostika Diagnostische Verwendung von Opiat-Antagonisten und -Agonisten enthaltende Präparationen zur Prophylaxe und therapeutischen Behandlung von Migräne und Migräne-verwandten Erkrankungen
GB9717629D0 (en) * 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents
US6114370A (en) * 1998-09-28 2000-09-05 Wall, Jr.; William H. Amnesic sedation composition and method of administering same
WO2006084389A1 (de) * 2005-02-11 2006-08-17 Cilag Ltd. Verfahren zur reinigung von noroxymorphon-verbindungen
JP2008546688A (ja) * 2005-06-16 2008-12-25 マリンクロッド・インコーポレイテッド １−ハロ−テバインまたは類似体を介する１４−ヒドロキシルオピエート類への合成経路
KR101421747B1 (ko) * 2006-04-21 2014-07-30 넥타르 테라퓨틱스 모르피논의 입체선택적 환원
EP2180000B1 (de) * 2007-05-04 2013-03-27 Mallinckrodt LLC Verbessertes Verfahren zur Herstellung von 6-alpha-hydroxy-n-alkylierten Opiaten
CA2693436A1 (en) * 2007-07-17 2009-01-22 Christopher W. Grote Preparation of n-alkylated opiates by reductive amination
WO2010017573A1 (en) * 2008-08-11 2010-02-18 Tasmanian Alkaloids Pty Limited PROCESS FOR MAKING MORPHINAN-6α-OLS
NZ607842A (en) 2008-09-30 2013-12-20 Mallinckrodt Llc Processes for the selective amination of ketomorphinans
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
JP5824448B2 (ja) 2009-04-24 2015-11-25 ブロック ユニバーシティ モルフィナンおよびモルフィノン化合物の調製法
EP2440561B1 (de) * 2009-06-11 2014-04-30 Mallinckrodt LLC Reduktive aminierung von 6-keto-normorphinanen durch katalytischen wasserstofftransfer
EP2440562B1 (de) * 2009-06-11 2016-08-10 Mallinckrodt LLC Herstellung von 6-alpha-amino-n-substituierten morphinanen durch katalytischen wasserstofftransfer
GB0914338D0 (en) 2009-08-17 2009-09-30 Johnson Matthey Plc Improved process
MY173491A (en) * 2010-01-29 2020-01-29 Toray Industries Therapeutic or prophylactic agent for biliary tract diseases
BR112013031420A2 (pt) 2011-06-09 2016-08-16 Mallinckrodt Llc "processo para preparar um 6-amino morfinano, composição que o compreende e composição compreendendo um composto intermediário"
CN103917543A (zh) 2011-09-08 2014-07-09 马林克罗特有限公司 在不分离中间体的情况下制备生物碱
WO2015066443A1 (en) 2013-11-01 2015-05-07 Mallinckrodt Llc Convenient preparation of n-substituted morphinan-6-ols from morphinan-6-ones
PL3065743T3 (pl) * 2013-11-07 2019-12-31 SpecGx LLC Sposób wytwarzania 6-hydroksymorfinanów bez izolowania związków pośrednich
CN110330500B (zh) * 2019-07-12 2021-11-23 宜昌人福药业有限责任公司 一种6β-羟基-7,8-二氢-吗啡衍生物的立体选择性合成方法
CN110305142B (zh) * 2019-07-12 2021-11-16 宜昌人福药业有限责任公司 一种6β-羟基吗啡衍生物的立体选择性合成方法
CN113845526B (zh) * 2021-01-18 2022-11-08 四川大学 一种蒂巴因衍生物及其制备方法和应用
CN112759596B (zh) * 2021-01-05 2022-03-15 宜昌人福药业有限责任公司 一种纳布啡的制备方法及其中间体
US20230255956A1 (en) * 2022-02-01 2023-08-17 HUMANWELL PHARMACEUTICAL US, Inc. Pharmaceutical formulations containing nalbuphine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3332950A (en) * 1963-03-23 1967-07-25 Endo Lab 14-hydroxydihydronormorphinone derivatives
IL26896A (en) * 1966-01-19 1970-11-30 Endo Lab 14 - Hydroxynormorphinins and 14 - Hydroxynormorphinones
US4795813A (en) * 1981-08-17 1989-01-03 The Florida Board Of Regents On Behalf Of The Florida State University Synthesis of derivatives of codeine and other 3-O-alkylmorphines
US5112975A (en) * 1984-03-27 1992-05-12 Mallinckrodt Specialty Chemicals Company Preparation of noroxymorphone from morphine

Also Published As

Publication number Publication date
US5756745A (en) 1998-05-26
AU699114B2 (en) 1998-11-19
HUT77409A (hu) 1998-04-28
CA2191843A1 (en) 1995-12-07
ATE176472T1 (de) 1999-02-15
JP4040673B2 (ja) 2008-01-30
AU2590295A (en) 1995-12-21
CA2191843C (en) 2006-05-02
WO1995032973A1 (en) 1995-12-07
NZ287243A (en) 1997-12-19
EP0763038A1 (de) 1997-03-19
ES2127532T3 (es) 1999-04-16
HU224914B1 (en) 2006-04-28
EP0763038B1 (de) 1999-02-03
DE69507697T2 (de) 1999-06-10
HU9603289D0 (en) 1997-01-28
JPH10501223A (ja) 1998-02-03

Similar Documents

Publication Publication Date Title
DE69507697T2 (de) Verfahren zur herstellung von nalbuphin das wenig des 6-beta-epimers enthält
ATE190222T1 (de) Verfahren zur herstellung von umhüllten tabletten
PT835257E (pt) Intermediarios e processo para o fabrico de derivados camptotecina (cpt-11) e compostos relacionados
AU6124696A (en) Control method for processes of synthesis of chemical products
ATE149196T1 (de) Verfahren zur herstellung von olefinen
DE68910083D1 (de) Verfahren zur Herstellung von harten Konfektprodukten, die hauptsächlich Xylitol enthalten.
DE69206226D1 (de) Verfahren zur Herstellung von mit Gas versetzten Süsswaren.
DE59606782D1 (de) Fachwerk und gefacheelement und verfarhren zur herstellung eines gefacheelements
DE69111534T2 (de) Verfahren zur Herstellung von Alpha-Olefin durch Ethenolyse.
DE69418581D1 (de) Verfahren zur herstellung dünner bleche, geeignet für die anfertigung von dosenteilen
HUP9601321A2 (en) Substituted (benzyloxy)-carbonyl-guanidine derivatives, process for producing them, pharmaceutical compositions containing them their use as pharmaceutical compositions or diagnostica, and the use of the said compds.
DE69822663D1 (de) Invert- bohremulsion, die durch umwandlung von olefinen hergestellte mischungen von sekundären estern enthält, und verfahren zur herstellung
DE69403087D1 (de) Verfahren zur herstellung von 9-(2-hydroxy)-ethoxy-guanin
DE58900821D1 (de) Verfahren zur herstellung von phosphororganischen derivaten des 2,4-di-t-butylphenols, der 4,4'-dihalogenmagnesium-verbindungen des biphenyls und die verwendung der phosphororganischen derivate zur stabilisierung von kunststoffen, insbesondere in polyolefinformmassen.
DE69514122D1 (de) Lösungsmittelfreies verfahren zur herstellung von 2,6 difluorbenzonitril
DE69414586D1 (de) Verfahren zur herstellung von indolizinderivaten
ATE101846T1 (de) Verfahren zur herstellung von 1,1dichlorotetrafluorethan.
ATE192437T1 (de) Verfahren zur herstellung von 3-amino-2-chlor-4- alkyl- bzw. 4-cycloalkyl-pyridine
DE59007022D1 (de) Verfahren zur kontinuierlichen Herstellung von Nylon 4,6.
DE68917284T2 (de) Verfahren zur Herstellung von Laminaten.
ATE175668T1 (de) Verfahren zur herstellung von 8-g(a),12-oxido- 13,14,15,16-tetranorlabdan
ATE215071T1 (de) Verfahren zur herstellung von prostaglandin e1
DE69404641D1 (de) Verfahren zur herstellung von 3,4-dihalogeno-1,2-epoxybutanen ausgehend von 3,4-epoxy-1-buten
ATE120187T1 (de) Verfahren zur herstellung von vitamin-d2- verbindungen und ihrer 1-alpha hydrogenierten derivate.
ATE183736T1 (de) Cycloalkanediole und ihre verwendung zur herstellung von chiralen verbindungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: VONNEMANN, KLOIBER & KOLLEGEN, 80796 MUENCHEN